Jun 26, 2020

A Study of Early-Onset Colorectal Cancer in Young Adult Men Reveals “Hotspots” of Death in the United States

Over the last three decades, colorectal cancer survival in the United States has improved significantly. But in young people incidence and mortality due to colorectal cancer are on the rise. Even among patients with early-stage colorectal cancer, racial disparities have grown more pronounced, with survival after colorectal cancer diagnosis poorer among African Americans compared with whites. Charles R. Rogers, PhD, MPH, MS, is working to better understand these factors in young people with colorectal cancer in order to help improve outcomes and reduce related disparities from this preventable disease.

Jun 02, 2020

Researchers Identify a Moving Target in Small Cell Lung Tumors

About 15 percent of lung cancers are classified as small cell lung cancer. Recent studies have indicated that four major subtypes of small cell lung cancer exist, yet approaches to tailor treatment of these subtypes have not yet become standard of care. Today in the journal Cancer Cell, scientists outline new findings about the origins of these lung cancer subtypes, paving the way for a new foundation to study this disease.

May 29, 2020

Huntsman Cancer Institute Researchers Demonstrate Better Outcomes, Lower Cost in First-Ever Oncology Hospital-at-Home Evaluation

Researchers at Huntsman Cancer Institute at the University of Utah presented the first outcomes evaluation of an adult oncology hospital-at-home program today at the 2020 American Society of Clinical Oncology annual meeting. The study evaluated patients participating in HCI’s Huntsman at HomeTM. The data demonstrate strong evidence for this care model, showing improved patient outcomes, including reduced hospitalizations and decreased visits to the emergency department.

May 27, 2020

Utah Researcher Awarded Prestigious Grant to Study New Ways to Detect Brain Tumors

Hunter Underhill, MD, PhD, a Huntsman Cancer Institute brain cancer researcher and assistant professor of pediatrics at the University of Utah, was awarded a special National Cancer Institute grant to advance his research in brain tumor detection. Underhill will pursue new ways to detect glioblastoma, a type of aggressive and deadly brain tumor.

May 26, 2020

Melanoma Research Innovations

At Huntsman Cancer Institute, we're committed to delivering a cancer-free frontier. Our cancer researchers are on the cutting-edge of discovery and innovation, and we're excited by what these advancements mean for melanoma prevention and treatment. Together, we're building the future we want.

May 08, 2020

2020 State of Huntsman Cancer Institute Address

On May 6, 2020, Huntsman Cancer Institute (HCI) CEO Mary Beckerle, PhD, gave her State of HCI address. This event is an annual tradition at HCI, where the CEO reports on progress of the past year and plans for the future. Less ordinary during this global coronavirus pandemic, however, was the format. Dr. Beckerle spoke to faculty and staff safely via live video stream.

Apr 29, 2020

Researchers Find New Insights Linking Cell Division to Cancer

Scientists at Huntsman Cancer Institute at the University of Utah and collaborators at the University of California, San Francisco published research in the journal Nature extending our understanding of the process of cell division. They discovered the protein LEM2 has two important functions during cell division.

Apr 24, 2020

Research Advancing Individualized Treatment for Metastatic Prostate Cancers

Prostate cancer is the second most common cancer for men in the United States. About one man in nine will be diagnosed with the disease at some point in his life. A study recently published in The Lancet’s EBioMedicine Journal describes new insights into how unique genetic traits of metastatic prostate tumors that are shed into the blood of cancer patients can be used for applying to the care of and potential molecularly targeted treatments in individual patients.